Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNV2197944 in Post-herpetic Neuralgia
NCT01848730Phase 2Completed
- Sponsor
- Convergence Pharmaceuticals
- Start
- Apr 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vixotrigine in postherpetic neuralgia (PHN), sponsored by Convergence Pharmaceuticals. Started Apr 2013; status: completed.
02
Drugs
vixotrigine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01848730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01848730.